BioCentury

Pharmaceutical Executive Europe

Pharmaceutical Executive Europe is the leading strategy based business management publication for senior executives, corporate strategists and sales & marketing leaders in the European pharmaceutical industry. Pharm Exec Europe now reaches over 18,000 readers on a bi-weekly basis in an easy to read digital format.

Tackling strategic business and marketing issues, Pharm Exec Europe provides complete high-quality analysis, opinion and industry news on critical trends and developments; sales and marketing strategies; corporate policy, management and branding; research and development; legislation; finance; new technologies.

Readers of Pharm Exec Europe include top C-suite pharmaceutical executives plus marketeers, contract organisations and management consultants, all with direct links to the pharmaceutical industry.

To subscribe to Pharm Exec Europe and for more information visit http://pharmexec.findpharma.com/Subscribe

Current Partnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers.

The core of our service is to provide access to latest best practice, business intelligence and information for dealmakers. We search out the latest information so you don’t have to and place it in one location, saving you precious time and resources.

CurrentPartnering is a publisher in its own right, publishing a series of reports each year and providing access to critical decision making and best practice intelligence from leaders in the partnering field.

Our most recent report titles include:

- Option & Evaluation Agreements in Pharma & Biotech
- Royalty Financing Terms and Agreements in Pharma, Biotech & Diagnostics, 2^nd Edition
- Practical Guide to Finding Partners in Pharma & Biotech, 3^rd Edition
- Clinical Stage Partnering Terms and Agreements in Pharma & Biotech, 2^nd Edition

For more information about us, please visit http://www.currentpartnering.com

Swiss Biotech Association

Swiss Biotech Association (SBA) was founded in March 1998. Today close to 200 companies represent this growing association. SBA is the industry association of small and medium-sized enterprises active in all areas of biotechnology as well as a very good networking platform for the multinational companies active in the sector. The membership is open to companies of various size concerned with different aspects of modern biotechnology such as R&D, production, marketing and sales, finance, services and consulting.

Activities of member companies span different sectors of biotechnology including (bio-)pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, marine-oriented research and specialty chemicals. The SBA is also managing the national Cluster for Biotechnology where the Swiss Life Science regions (BaselArea, Berne Capital Area, BioAlps, Biopolo Ticino, Greater Zurich Area), the finance market (SIX) and the industry work together to promote Switzerland as a key Biotech country.

Innovaro Pharmalicensing

Innovaro Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Innovaro Pharmalicensing, and its newly launched sister service Innovaro Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 190,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Corporation, listed on AMEX (INV).

Going Public

Pharmawire

Pharmawire publishes real-time news and data on the most price sensitive issues in the global pharmaceutical market. Built for financial professionals, Pharmawire covers product approvals, litigation, licensing deals and M & A. Pharmawire is a part of The Mergermarket Group, a division of the Financial Times Group, publisher of the Financial Times newspaper and FT.com. The FT Group is a division of Pearson plc, the international media group.

Visit www.pharmawire.com

BioSpace

HBM Partners

HBM Partners is among the global leaders in Life Science-focused investing with approximately USD 1 billion under management. HBM’s advisory business was founded in 2001 with the vision to invest across the life cycle of healthcare companies, from venture-backed early-stage all the way to listed companies.

HBM Partners manages several private-equity funds as well as cross-over and public equity funds. Our companies' teams of professionals have a thorough understanding of the biotech, medtech and diagnostics industries through active investing in both private and public companies. The teams' experts have substantial operational and financial industry experience. Since inception we have invested in over 100 companies and in most of them we actively contribute to value creation through management support and board participation.

Sweden Bio

Pharma TV

European Life Science

Pharma Ventures

College Hill Life Science

College Hill Life Sciences is a full service communications consultancy focused on science-based sectors. Within the life science field we have established a leadership position by working in partnership with our clients to deliver high quality communications that build value and promote leading edge products, technologies and services.

Our scientific, technical and business backgrounds, coupled with our extensive experience in the sector internationally provide a solid knowledge base from which our clients can build and implement their communications strategy. Added to this, our understanding of the public, commercial and financial issues gives us a mix of skills and expertise not easily found elsewhere.

We work with a range of businesses within the science arena, from start-ups to some of the leading multinational corporations. Our current client base spans biotechnology, pharma, laboratory supplies, service providers, medical devices, diagnostics, healthcare companies as well as venture capitalists, academic organisations, and science-associated bodies.

The Hungarian Biotechnology Association (HBA) was established by Hungary’s leading life science companies in 2003. The main objective of the organization is to create an alliance that unites the voice and interests of companies, researchers, academic institutions and related organizations to provide them with shared services, advocacy, and to help them find success and opportunities in the field of life sciences. HBA regards the representation of Hungary’s biotechnology sector as its most important activity. Furthermore, the Association’s goals include winning governmental support for the biotechnology sector – in order to reach this, the organization prepares documents and carries out harmonized lobbying activities. HBA is also a member of various international biotechnological organizations such as EuropaBio, the Biotechnology Industry Organization and the European Federation of Biotechnology.

Contacts:
Address: H-6726 Szeged, Kozep fasor 52.
Tel.:+36 62 312 559
Fax:+ 36 62 420 617
e-mail: info@hungarianbiotech.org
website: www.hungarianbiotech.org